Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-01-21 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document text is very short (275 characters) and is written in Danish. It references a previous company announcement ('Selskabsmeddelelse nr. 1, 2014') regarding the awarding of shares from an incentive program ('incitamentsprogrammet') upon achieving a set goal. Crucially, the last line states, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). According to Rule #2 (The 'MENU VS MEAL' Rule), a short document that directs the reader to a separate PDF for the full content is classified as a Report Publication Announcement (RPA). While the content relates to capital/share structure, the format strongly suggests an announcement of publication rather than the detailed filing itself. Since RPA is available, it is the most appropriate fit over the general RNS fallback.
2014-01-21 Danish
Remuneration Information 2014
Remuneration Information Classification · 99% confidence The document explicitly states that it is reporting 'transactions in Novozymes B shares' involving the Executive Leadership Team receiving allocated stock from an incentive program. This directly relates to personal share transactions by company directors and executives (insider trades). This aligns perfectly with the definition for Director's Dealing (DIRS). The document is short and contains specific transaction details, not a general announcement of a report.
2014-01-21 English
Report Publication Announcement 2014
Report Publication Announcement Classification · 98% confidence The document text is extremely short ("Please read the full announcement in PDF format.") and explicitly directs the user to a PDF for the full content. This strongly indicates that the provided text is merely an announcement about the publication of a report, rather than the report itself. According to Rule 2 (The 'Menu vs Meal' Rule), this should be classified as a Report Publication Announcement (RPA).
2014-01-21 English
Earnings Release 2013
Earnings Release Classification · 100% confidence The document provides a summary of financial performance for the year 2013, including key metrics like sales growth, EBIT, net profit, and EBIT margin. It also provides a positive outlook for 2014, including specific guidance ranges. This content structure—summarizing past period results and providing forward guidance—is characteristic of an Earnings Release (ER). The final line, 'Read the full announcement in PDF format,' suggests this text is an excerpt or summary, but the core content is the financial results announcement itself, not just an announcement *about* the release (which would be RPA). Therefore, ER is the most appropriate classification. FY 2013
2014-01-21 English
Earnings Release 2013
Earnings Release Classification · 99% confidence The document text is dated '21. januar 2014' and provides a comprehensive review of the full financial year 2013 ('2013 som ventet') including detailed income statements, segment breakdowns (Sales by Industry, Geographic Distribution), balance sheet items (Costs, Operating Income), and forward-looking guidance for 2014. The content is highly detailed, covering revenue, operating profit, margins, and capital expenditures for the entire fiscal year. This level of detail and annual scope strongly indicates a full Annual Report, which corresponds to the 10-K filing type in the US context, or its equivalent for comprehensive annual financial disclosure. Since the document is extensive (91,211 characters) and contains the full financial results, it is classified as the report itself, not just an announcement (RPA/RNS). FY 2013
2014-01-21 English
Share Issue/Capital Change 2013
Share Issue/Capital Change Classification · 99% confidence The document announces two major corporate actions: the financial impact of a new strategic alliance (The BioAg Alliance with Monsanto) and the initiation of a new stock buyback program worth up to DKK 2 billion. Announcements detailing share repurchase plans (Transaction in Own Shares) and significant capital structure adjustments are typically classified under 'Transaction in Own Shares' (POS) or 'Capital/Financing Update' (CAP). Since the primary focus is the decision to buy back shares and the associated capital structure adjustment, 'POS' is highly relevant. However, the document also details significant financial guidance changes (sales, margins, EBIT) related to the alliance, which often accompanies an Earnings Release (ER) or Management Discussion & Analysis (MDA). Given the explicit announcement of a 'new stock buyback program' and the mechanics of share reduction, 'POS' (Transaction in Own Shares) is the most specific fit for the capital action described, even though it contains forward-looking financial guidance. It is not a full 10-K, IR, or ER, but a specific corporate action announcement.
2013-12-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.